Neurolens

About:

Neurolens designs prescription lenses that add a contoured prism to bring the eyes into alignment.

Website: https://www.neurolenses.com

Top Investors: Bluestem Capital, Marshall Wace, MVM Life Science Partners, Trinary Capital, Falcon Vision

Description:

Neurolens are prescription lenses that add a contoured prism to bring the eyes into alignment, relieving the headaches, neck or shoulder pain, and eyestrain that many people experience when using digital devices, reading, or doing detailed work. The company was founded in 2012 and is headquartered in Costa Mesa, California.

Total Funding Amount:

$186M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Coppell, Texas, United States

Founded Date:

2012-06-01

Contact Email:

info(AT)eyebrainmedical.com

Founders:

Davis Corley

Number of Employees:

101-250

Last Funding Date:

2023-12-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai